Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinoma
Stereotactic ablative body radiotherapy is an effective treatment option, with acceptable decline in renal function and toxicity for medically inoperable patients with complex primary kidney tumours. The association between baseline RNS and renal function trajectories is worthy of further investigation.
Authors
- Renu Eapen (ORCID: https://orcid.org/0000-0003-0590-6234)
- Nicholas Hardcastle (ORCID: https://orcid.org/0000-0001-7796-8472)
- Mark Shaw
- Mathias Bressel (ORCID: https://orcid.org/0000-0002-9718-9596)
- Marlon Perera (ORCID: https://orcid.org/0000-0002-1138-6389)
- Sarat Chander (ORCID: https://orcid.org/0000-0002-1803-049X)
- Arun Azad (ORCID: https://orcid.org/0000-0001-7350-5622)
- Nathan Lawrentschuk (ORCID: https://orcid.org/0000-0001-8553-5618)
- Shankar Siva (ORCID: https://orcid.org/0000-0003-2840-0658)
- Muhammad Shaiq Ali (ORCID: https://orcid.org/0000-0002-3337-2818)
- Declan G. Murphy (ORCID: https://orcid.org/0000-0002-7500-5899)
- Rajeev Ravi
- Sheng F. Oon (ORCID: https://orcid.org/0000-0002-4309-9405)
- David Chang
Institutions
- The Royal Melbourne Hospital (AU)
- The University of Melbourne (AU)
- University of Wollongong (AU)
- Peter MacCallum Cancer Centre (AU)
- Melbourne Clinic (AU)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2025-06-28
- DOI
- https://doi.org/10.1111/bju.16843
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Australian Government
- University of Melbourne
- Cancer Council Victoria